[1] [3] According to the UK SmPC, dosing starts at 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks until the target dose (5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) is reached, based on individual response and tolerability
We ensure its safe alongside other medications or health conditions, including digestive and kidney diseases
Discuss this with your provider
Prevents over-secretion of glucagon: Glucagon is a hormone that tells the liver to send more glucose into the bloodstream when blood sugar levels are low
Mortality and Major Adverse Cardiac Events (MACE) with GLP-1 Receptor Agonists in Psoriatic Arthritis
Surgeons need metabolic status, anesthesiologists require drug profiles, and primary care/endocrinology must set targets and titrate meds